REQUEST A DEMO
Total
USD $0.00
Search more companies

Establo Pharma Sp. z o.o. (Poland)

Main Activities: All Other Food Manufacturing
Secondary Activities: All Other Miscellaneous Food Manufacturing | General Line Grocery Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Wholesale Trade Agents and Brokers | All Other General Merchandise Stores | Advertising Agencies | Marketing Research and Public Opinion Polling
Full name: Establo Pharma Sp. z o.o. Profile Updated: May 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

establo pharma sp. z o.o is a pharmaceutical company. The company operates in the pharmaceutical industry, focusing on innovative products and modern technology.

Headquarters
Ul. Chemiczna 8 J
Lublin; Lubelskie; Postal Code: 20-329

Contact Details: Purchase the Establo Pharma Sp. z o.o. report to view the information.

Website: http://www.establopharma.com

Basic Information
Total Employees:
Purchase the Establo Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Establo Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Establo Pharma Sp. z o.o. report to view the information.
Incorporation Date:
September 08, 2010
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
36%
Purchase this report to view the information.
34%
Company Performance
Financial values in the chart are available after Establo Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
4.65%
Total operating revenue
4.01%
Operating profit (EBIT)
9005.57%
EBITDA
1817.21%
Net Profit (Loss) for the Period
N/A
Total assets
-27.72%
Total equity
30.59%
Operating Profit Margin (ROS)
8.72%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-22.58%
Quick Ratio
0.49%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?